abstract |
The present invention relates to 3- (6- (1- (1- (2,2-difluorobenzo [d] [1,3] dioxol-5-yl) cyclopropanecarboxamido) -3-methylpyridine of formula (I). -2-yl) benzoic acid in a substantially crystalline and free solid state form (Form I), pharmaceutical compositions thereof and methods of treatment associated therewith. Formula I |